Scarica l'app Stockscreener
15.41
0.26%
0.04
Dopo l'orario di chiusura:
15.58
0.17
+1.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNDM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$15.37
Aprire:
$15.46
Volume 24 ore:
1.32M
Relative Volume:
0.57
Capitalizzazione di mercato:
$1.06B
Reddito:
$1.03B
Utile/perdita netta:
$-94.55M
Rapporto P/E:
-11.00
EPS:
-1.4012
Flusso di cassa netto:
$-3.64M
1 W Prestazione:
+0.59%
1M Prestazione:
-5.05%
6M Prestazione:
-28.99%
1 anno Prestazione:
-4.70%
Intervallo 1D:
$15.00
$15.50
Intervallo di 1 settimana:
$14.80
$15.86
Portata 52W:
$9.98
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Nome
Tandem Diabetes Care Inc
Settore
Industria
Telefono
858-366-6900
Indirizzo
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
15.41 | 1.06B | 1.03B | -94.55M | -3.64M | -1.4012 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-19 | Aggiornamento | Truist | Hold → Buy |
| 2026-03-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2026-02-23 | Aggiornamento | Lake Street | Hold → Buy |
| 2026-02-20 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2026-01-27 | Ripresa | TD Cowen | Buy |
| 2025-12-16 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | Ripresa | Stifel | Hold |
| 2025-09-08 | Iniziato | Oppenheimer | Outperform |
| 2025-08-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2025-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Downgrade | Citigroup | Neutral → Sell |
| 2025-06-16 | Iniziato | Truist | Hold |
| 2025-04-10 | Iniziato | Mizuho | Neutral |
| 2025-03-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Downgrade | Citigroup | Buy → Neutral |
| 2025-03-03 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Iniziato | Bernstein | Outperform |
| 2024-10-04 | Iniziato | Goldman | Neutral |
| 2024-10-02 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-08-22 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Iniziato | Canaccord Genuity | Buy |
| 2024-05-30 | Iniziato | Redburn Atlantic | Buy |
| 2024-05-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-04-29 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Aggiornamento | Stifel | Hold → Buy |
| 2023-08-04 | Downgrade | Citigroup | Buy → Neutral |
| 2023-05-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-26 | Iniziato | Wolfe Research | Peer Perform |
| 2022-11-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-08-09 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Iniziato | Wells Fargo | Overweight |
| 2020-07-31 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-07-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-06-18 | Reiterato | Raymond James | Outperform |
| 2020-04-24 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-06 | Iniziato | Raymond James | Outperform |
| 2020-02-04 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Iniziato | Guggenheim | Buy |
| 2019-10-04 | Aggiornamento | UBS | Neutral → Buy |
| 2019-05-17 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-13 | Iniziato | SVB Leerink | Outperform |
| 2019-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2019-03-05 | Reiterato | BofA/Merrill | Neutral |
| 2019-02-27 | Reiterato | Lake Street | Buy |
| 2018-11-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Reiterato | Dougherty & Company | Buy |
| 2018-09-26 | Reiterato | Piper Jaffray | Overweight |
Mostra tutto
Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie
Is Tandem Diabetes Care (TNDM) Undervalued Following Its Abbott Libre 3 Plus Expansion? - Yahoo Finance
Tandem’s Expanded Libre 3 Plus Integration Could Be A Game Changer For Tandem Diabetes Care (TNDM) - Sahm
Understanding the Setup: (TNDM) and Scalable Risk - Stock Traders Daily
Tandem Diabetes Care Inc. (TNDM) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Tandem Diabetes Care (TNDM) Goldman Sachs 46th Annual Global Healthcare Conference summary - Quartr
Citi Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $17 - Moomoo
Tandem Diabetes Care (TNDM) Stifel 2024 Healthcare Conference Summary - Quartr
Does TNDM Stock Still Deserve a Place in Your Portfolio? - Yahoo Finance
Is the Market Underestimating Tandem Diabetes Care, Inc. (TNDM)’s Transition Risks? - Insider Monkey
10 Best Get Rich Quick Stocks to Buy Right Now - Insider Monkey
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility With Abbott's FreeStyle Libre 3 Plus CGM Sensor - Medical Product Outsourcing
Tandem Diabetes Q1 2026 slides: record revenue, profitability returns - Investing.com
TNDMTandem Diabetes Care Inc Options - Finviz
Tandem Diabetes faces earnings test as pay-as-you-go shift weighs - Investing.com
ETFs Investing in Tandem Diabetes Care, Inc. Stocks - TradingView
TANDEM DIABETES CARE INC (TNDM) Stock Chart - ChartMill
Insulin pump makers Tandem and Insulet post contrasting Q2 results - MSN
Diabetes warning issued over insulin pump error - MSN
Tandem Diabetes Care (TNDM) Expands Compatibility with Abbott's FreeStyle Libre 3 Plus - GuruFocus
Tandem's t:slim X2 insulin pump now compatible with Abbott's FreeStyle Libre 3 Plus CGM in five countries - Medical Economics
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets - Yahoo Finance
Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026 - Moomoo
Why Tandem Diabetes (TNDM) shares are sliding today - MSN
Why Tandem Diabetes (TNDM) Shares Are Sliding Today - Yahoo Finance
Tandem Diabetes Care, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.066666 Sh - TradingView
Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? - Stocktwits
Press Release: Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026 - 富途牛牛
The Technical Signals Behind (TNDM) That Institutions Follow - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC (TNDM) Investigation: Bronstei - The National Law Review
DexCom, Insulet gain news Buys at Deutsche Bank despite recent selloff - MSN
Tandem Diabetes Care, Inc. Actuals & Estimates (NASDAQ:TNDM) - TradingView
Tandem Diabetes Care, Inc. Actuals & Estimates (DUS:TD5A) - TradingView
TD5A Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Tandem Diabetes Care, Inc. – NASDAQ:TNDM - TradingView
Tandem Diabetes Care, Inc. Actuals & Estimates (BMV:TNDM) - TradingView
Tandem insulin pumps cleared in EU for expanded indications - MSN
Price to sales forward of Tandem Diabetes Care, Inc. – NASDAQ:TNDM - TradingView
Enterprise value to EBIT forward of Tandem Diabetes Care, Inc. – NASDAQ:TNDM - TradingView
Enterprise value to EBITDA forward of Tandem Diabetes Care, Inc. – NASDAQ:TNDM - TradingView
What Does Tandem Diabetes Care's Upsized Convertible Note Offering Mean for Investors - Kavout | AI
Tandem Diabetes Care, Inc. Actuals & Estimates (BIVA:TNDM) - TradingView
TNDM stock down following Q1 earnings & revenue beat, gross margin up - MSN
TNDM Forecast — Price Target — Prediction for 2027 - TradingView
Tandem Diabetes Care Inc (TNDM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tandem Diabetes rises on Wells Fargo upgrade - MSN
TNDM Initiated Coverage by Deutsche Bank -- Rating Set to Hold - GuruFocus
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Deutsche Bank Initiates Coverage on Tandem Diabetes Care With Hold Rating, $15.50 Price Target - marketscreener.com
Tandem Diabetes Care Inc (TNDM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tandem Diabetes Care Inc (TNDM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tandem Diabetes Care Inc (TNDM) Institutional Confidence - TradingKey
Tandem Diabetes Care Inc Azioni (TNDM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):